Literature DB >> 1380285

Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis.

G Baranton1, D Postic, I Saint Girons, P Boerlin, J C Piffaretti, M Assous, P A Grimont.   

Abstract

We studied 48 Borrelia isolates that were associated with Lyme borreliosis or were isolated from ticks and identified three DNA relatedness groups by using the S1 nuclease method. The three DNA groups (genospecies) were associated with specific rRNA gene restriction patterns, protein electrophoresis patterns, and patterns of reactivity with murine monoclonal antibodies. Genospecies I corresponded to Borrelia burgdorferi sensu stricto since it contained the type strain of this species (strain ATCC 35210); this genospecies included 28 isolates from Europe and the United States. Genospecies II was named Borrelia garinii sp. nov. and included 13 isolates from Europe and Japan. Genospecies III (group VS461) included seven isolates from Europe and Japan.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1380285     DOI: 10.1099/00207713-42-3-378

Source DB:  PubMed          Journal:  Int J Syst Bacteriol        ISSN: 0020-7713


  285 in total

1.  Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe.

Authors:  U Hauser; G Lehnert; B Wilske
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

Review 2.  Molecular detection of pathogen DNA in ticks (Acari: Ixodidae): a review.

Authors:  O A Sparagano; M T Allsopp; R A Mank; S G Rijpkema; J V Figueroa; F Jongejan
Journal:  Exp Appl Acarol       Date:  1999-12       Impact factor: 2.132

3.  Molecular and evolutionary characterization of the cp32/18 family of supercoiled plasmids in Borrelia burgdorferi 297.

Authors:  M J Caimano; X Yang; T G Popova; M L Clawson; D R Akins; M V Norgard; J D Radolf
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

4.  Molecular and evolutionary analysis of Borrelia burgdorferi 297 circular plasmid-encoded lipoproteins with OspE- and OspF-like leader peptides.

Authors:  D R Akins; M J Caimano; X Yang; F Cerna; M V Norgard; J D Radolf
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

5.  Characterization of Borrelia burgdorferi isolated from erythema migrans lesions: interrelationship of three molecular typing methods.

Authors:  R Iyer; D Liveris; A Adams; J Nowakowski; D McKenna; S Bittker; D Cooper; G P Wormser; I Schwartz
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

6.  PCR-Based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-Day postinfection period.

Authors:  R K Straubinger
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

7.  Spirochetal non-Borrelia-microorganism isolated from Ixodes ricinus.

Authors:  K Schwarzová; I Ciznár
Journal:  Folia Microbiol (Praha)       Date:  1996       Impact factor: 2.099

8.  Identification of a new Borrelia species among small mammals in areas of northern Spain where Lyme disease is endemic.

Authors:  Horacio Gil; Marta Barral; Raquel Escudero; Ana L García-Pérez; Pedro Anda
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

9.  Prevalence of Borrelia burgdorferi species and identification of Borrelia valaisiana in questing Ixodes ricinus in the Lyon region of France as determined by polymerase chain reaction-restriction fragment length polymorphism.

Authors:  T Quessada; F Martial-Convert; S Arnaud; H Leudet De La Vallee; B Gilot; J Pichot
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-02-27       Impact factor: 3.267

10.  Differential immune responses to Borrelia burgdorferi in European wild rodent species influence spirochete transmission to Ixodes ricinus L. (Acari: Ixodidae).

Authors:  K Kurtenbach; A Dizij; H M Seitz; G Margos; S E Moter; M D Kramer; R Wallich; U E Schaible; M M Simon
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.